posted on Jun 08 by MedPage Today OB/Gyn in the Uncategorized category
CHICAGO (MedPage Today) -- Trabectedin may have a role in the treatment of recurrent ovarian cancer while sparing patients for a time from platinum-based regimens, according to several studies presented here.